Cargando…

Comparison of Early and Late Conversion of Sirolimus in Experimental Model of Chronic Cyclosporine Nephropathy

Sirolimus (SRL) is a promising drug for replacing calcineurin inhibitors. We performed this study to determine the optimal time of conversion from cyclosporine (CsA) to SRL in an experimental model of chronic CsA nephropathy. Three separate studies were performed. In the first study, SRL was given t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin Young, Ghee, Jung Yeon, Lim, Sun Woo, Piao, Shang Guo, Chung, Byung Ha, Yoon, Hye Eun, Hwang, Hyeon Seok, Choi, Bum Soon, Kim, Jin, Yang, Chul Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271289/ https://www.ncbi.nlm.nih.gov/pubmed/22323863 http://dx.doi.org/10.3346/jkms.2012.27.2.160

Ejemplares similares

Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model
por: Sereno, José, et al.
Publicado: (2012)

Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency
por: Joo, Dong Jin, et al.
Publicado: (2014)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

The combined use of sirolimus and cyclosporin in the management of refractory minimal change nephropathy: ‘a novel use of sirolimus’
por: Davison, Rachel, et al.
Publicado: (2009)

Induction of PPAR Gamma mRNA and Protein Expression by Rosiglitazone in Chronic Cyclosporine Nephropathy in the Rat
por: Ahn, Kyung Ohk, et al.
Publicado: (2007)

Established and Newly Proposed Mechanisms of Chronic Cyclosporine Nephropathy
por: Yoon, Hye Eun, et al.
Publicado: (2009)

Conversion to Sirolimus Ameliorates Cyclosporine-Induced Nephropathy in the Rat: Focus on Serum, Urine, Gene, and Protein Renal Expression Biomarkers
por: Sereno, José, et al.
Publicado: (2014)

Activation of Intrarenal Complement System in Mouse Model for Chronic Cyclosporine Nephrotoxicity
por: Kim, Young Ok, et al.
Publicado: (2007)

Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats
por: Jin, Jian, et al.
Publicado: (2017)

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
por: Foroutan, Naghmeh, et al.
Publicado: (2013)

The effects of addition of coenzyme Q10 to metformin on sirolimus-induced diabetes mellitus
por: Sun, In O, et al.
Publicado: (2019)

Oral Administration of Ginseng Ameliorates Cyclosporine-Induced Pancreatic Injury in an Experimental Mouse Model
por: Lim, Sun Woo, et al.
Publicado: (2013)

Human Adipose Tissue Derived Mesenchymal Stem Cells Aggravate Chronic Cyclosporin Nephrotoxicity by the Induction of Oxidative Stress
por: Chung, Byung Ha, et al.
Publicado: (2013)

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy
por: Kim, Yaeni, et al.
Publicado: (2019)

Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
por: Silva, Jacqueline D., et al.
Publicado: (2023)

The role of sirolimus in proteinuria in diabetic nephropathy rats
por: Wang, JinJun, et al.
Publicado: (2017)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Expression of brain-derived neurotrophic factor in kidneys from normal and cyclosporine-treated rats
por: Tao, Yuan Sheng, et al.
Publicado: (2018)

Update of aristolochic acid nephropathy in Korea
por: Ban, Tae Hyun, et al.
Publicado: (2018)

Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Pemphigus Vulgaris
por: Park, So Eun, et al.
Publicado: (2015)

Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients
por: Lee, Hae Min, et al.
Publicado: (2015)

Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
por: Bohra, Rahul, et al.
Publicado: (2012)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Immunological benefits by ginseng through reciprocal regulation of Th17 and Treg cells during cyclosporine-induced immunosuppression
por: Heo, Seong Beom, et al.
Publicado: (2016)

Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young rats
por: Kim, Ji Hong, et al.
Publicado: (2016)

Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling
por: Hong, Yu Ah, et al.
Publicado: (2014)

Effects of Cyclosporin A Therapy Combined with Steroids and Angiotensin Converting Enzyme Inhibitors on Childhood IgA Nephropathy
por: Shin, Jae Il, et al.
Publicado: (2010)

Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
por: O'Connell, Séin, et al.
Publicado: (2012)

In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus against Aspergillus Species
por: Schwarz, Patrick, et al.
Publicado: (2020)

Extensive Late-Acquired Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation
por: Choi, Hyun-Chul, et al.
Publicado: (2010)

Sirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results
por: Thervet, Eric
Publicado: (2006)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
por: Baek, Jong Ha, et al.
Publicado: (2021)

Comparative analysis of 0.1% cyclosporin A cationic emulsion and 0.05% cyclosporin A emulsion in murine dry eye cases with different severities
por: Jin, Rujun, et al.
Publicado: (2021)

Role of Klotho in Chronic Calcineurin Inhibitor Nephropathy
por: Luo, Kang, et al.
Publicado: (2019)

Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains
por: Sun, In O, et al.
Publicado: (2012)

Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy
por: Woo, Ha Na, et al.
Publicado: (2012)

Simultaneous Determination of Cyclosporine A, Tacrolimus, Sirolimus, and Everolimus in Whole-Blood Samples by LC-MS/MS
por: Karapirli, Mustafa, et al.
Publicado: (2012)

Application of Allogeneic Bone Marrow Cells in View of Residual Alloreactivity: Sirolimus but Not Cyclosporine Evolves Tolerogenic Properties
por: Timrott, Kai, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g5jfv8cmckn9m6mgs03ejqn4m1